BBH: Buy Rating, As Tech Investors Look Beyond FAANG

VanEck Biotech ETF tracks top U.S.-listed biotech companies, offers exposure to innovative therapies and technologies. Biotechnology sector experiencing exponential growth driven by emerging technologies addressing global challenges. The VanEck biotech ETF (BBH) is under-discovered compared to peers, offers potential for trend change in biotech sector.

Weekly Report: what happened at BBH last week (0715-0719)?

Biogen Earnings Preview: What to Expect

Biogen Inc. Is set to announce its fiscal Q2 earnings results before the market opens on Thursday, Aug. 1. The company is renowned for its innovative therapies for neurological and neurodegenerative diseases. Biogen reported its Q1 earnings on Apr. 24. BIIB stock is down 11.8% on a YTD.

What You Need to Know Ahead of Amgen's Earnings Release

Amgen Inc. Is set to announce its fiscal Q2 earnings results after the market closes on Tuesday, Aug. 6. The company is expected to report a profit of $4.87 per share. Amgen stock is up 15.7% on a YTD basis.

ASCO Annual Meeting 2024: Breakthrough Treatments Hint At Renewed Hope For Patients And Investors

Weekly Report: what happened at BBH last week (0708-0712)?

Q3 2024 Equity Market Outlook

Home Market Outlook Today's Market Q3 2024 Equity Market Outlook: Neuberger Berman 2.93K Followers. We expect further corporate earnings growth across sectors, fueled by rising household net worth and a global industrial rebound. We recommend overweighting technology, communications and consumer discretionary stocks.

Weekly Report: what happened at BBH last week (0701-0705)?

CDT Insider Sentiment June 2024: Keep Your Seatbelt Fastened

Equity Outlook: Making Way For The Magnificent Others

Global stocks posted healthy gains in the first half of 2024. Despite narrow market concentration, we see opportunities in high-quality stocks that haven't yet been rewarded. With inflation still high and equity returns concentrated, the time may be right for investors to broaden their horizons. Equity Outlook: Making way for the Magnificent Others.

Midyear Equity Outlook - Investing Beyond The Megacaps

Home Investing Strategy Portfolio Strategy Midyear Equity Outlook - Investing Beyond The Megacaps by Nelson Yu. The best performing sector has been technology with all of the AI powering the technology gains. Inflation has actually been more selective than the world expected. Lagging the stock market is consumer, not surprisingly.

Weekly Report: what happened at BBH last week (0624-0628)?

From AI To Green Metals: Strategic Investments For A Changing World

Green transition is driving this unprecedented demand for metals and minerals. By 2030, we will need 50 new lithium mines to meet the growing demand for electric vehicles (EVs) and renewable energy infrastructure. The clean appearance of EVs, solar panels, and windmills belies the dirty reality that they require lots and lots of mining.

Biotech ETF (BBH) Hits New 52-Week High

Weekly Report: what happened at BBH last week (0617-0621)?

Weekly Report: what happened at BBH last week (0610-0614)?

Should You Invest in the VanEck Biotech ETF (BBH)?

Weekly Report: what happened at BBH last week (0603-0607)?

What The 2024 Elections Could Mean For Health Care Investors

Health care spending now accounts for 17% of the U.S. GDP. Election year volatility could mean opportunity for health care investors. The fate of medical exchanges and providers could be impacted by the election outcome. The outcome of the presidential election in 2024 could have implications for the health care sector.

Weekly Report: what happened at BBH last week (0527-0531)?